Deteriorative Effect of a Combination of Hypertriglyceridemia and Low High-Density Lipoprotein Cholesterolemia on Target Lesion Revascularization after Everolimus-Eluting Stent Implantation-Reference-Cited by-同舟云学术

Deteriorative Effect of a Combination of Hypertriglyceridemia and Low High-Density Lipoprotein Cholesterolemia on Target Lesion Revascularization after Everolimus-Eluting Stent Implantation

Published:2023-12-01 Issue:12 Volume:30 Page:1778-1790
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:JAT

Author:

Kimura Masahiro¹,Takeda Teruki¹,Tsujino Yasushi¹,Matsumoto Yuichi¹,Yamaji Masayuki¹,Sakaguchi Tomoko¹,Maeda Keiko¹,Mabuchi Hiroshi¹,Murakami Tomoyuki¹

Affiliation:

1. Department of Cardiovascular Medicine, Koto Memorial Hospital, Shiga, Japan

Publisher

Japan Atherosclerosis Society

Subject

Biochemistry (medical),Cardiology and Cardiovascular Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/jat/30/12/30_64010/_pdf

Reference47 articles.

1. 1) Silber S, Windecker S, Vranckx P, and Serruys PW: Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trial. Lancet, 2011; 377: 1241-1247

2. 2) Stone GW, Rizvi A, Newman W, Mastali K, Wang JC, Caputo R, Doostzadeh J, Cao S, Simonton CA, Sudhir K, Lansky AJ, Cutlip DE, and Kereiakes DJ: Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease. N Engl J Med, 2010; 362: 1663-1674

3. 3) Stone GW, Rizvi A, Sudhir K, Newman W, Applegate RJ, Cannon LA, Maddux JT, Cutlip DE, Simonton CA, Sood P, and Kereiakes DJ: Randomized comparison of everolimus- and paclitaxel-eluting stents. 2-year follow-up from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) IV trial. J Am Coll Cardiol, 2011; 58: 19-25

4. 4) Fujita T, Takeda T, Tsujino Y, Yamaji M, Sakaguchi T, Maeda K, Mabuchi H, Murakami T, Morimoto T, and Kimura T: Effect of glycemic control during follow-up on late target lesion revascularization after implantation of new-generation drug-eluting stents in patients with diabetes - A single-center observational study. Circ Rep, 2020; 2: 479-489

5. 5) Asada K, Takeda T, Higo Y, Sawayama Y, Yagi N, Fukuyama M, Yamaji M, Sakai H, Mabuchi H, Yamamoto T, and Nakagawa Y: Impact of statin therapy on late target lesion revascularization after everolimus-eluting stent implantation according to pre-interventional vessel remodeling and vessel size of treated lesion. Heart Vessels, 2022; 37: 1817-1828

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Letter to the editor: Drug-coated balloon angioplasty versus drug-eluting stent implantation in ACS patients with different angiographic patterns of in-stent restenosis;International Journal of Cardiology;2024-12

2. Relationship between Atherogenic Dyslipidemia and Target Lesion Revascularization Post Everolimus-Eluting Stent Implantation;Journal of Atherosclerosis and Thrombosis;2023-12-01